Business Wire

Aga Khan Museum Launches Season 5 of This Being Human as a Multimedia Video Podcast with new host, Mai Habib

21.4.2026 16:00:00 EEST | Business Wire | Press release

Share

The highly anticipated launch of Season 5 of This Being Human marks a dynamic new chapter for the Aga Khan Museum’s acclaimed podcast, expanding both its reach and storytelling. Now hosted by former journalist and cultural advocate Mai Habib, the new season brings listeners into compelling dialogue with artists and thought leaders whose work offers a global perspective on art and culture, identity, and new and pressing ideas that shape humanity today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421929514/en/

This Being Human Podcast Logo, Courtesy of the Aga Khan Museum

Building on an impressive footprint of more than 100 episodes over the past four seasons, This Being Human will evolve into an audiovisual experience for the first time. Each of the 12 episodes will be filmed and released on YouTube alongside all major podcast platforms, inviting audiences into a more immersive encounter with the voices shaping these conversations. The new format expands the series’ exploration of lived experience, creativity, and connection across cultures.

Featuring artists and collaborators with ties to the Museum, Season 5 highlights voices such as Gary Kamemoto, Principal Architect from Maki and Associates, the firm behind the Museum’s architectural design, Dr. Christiane Gruber, Professor of Islamic Art at the University of Michigan, and Ohida Khandakar, a visual artist and filmmaker — each offering distinct perspectives that move across disciplines such as architecture, scholarship, and visual culture.

This season also introduces a new editorial partnership with The Walrus, one of Canada’s leading publications dedicated to ideas, culture, and public discourse.

This Being Human has evolved into a prominent platform for global conversations on art, creativity, and the ways culture shapes how we see ourselves and one another,” said Dr. Sascha Priewe, Director, Collections and Public Programs, at the Aga Khan Museum. “With Mai Habib as host and the introduction of an audiovisual format, Season 5 builds on the first four seasons and brings audiences closer to the voices and lived experiences that define our shared humanity, while expanding the Museum’s role as a space for dialogue across cultures.”

This Being Human is available on major podcast platforms, including Spotify and Apple Podcasts. The first episode of Season 5 launches on April 28, with new episodes released monthly.

Visit agakhanmuseum.org/thisbeinghuman for more details.

About the Aga Khan Museum

The Aga Khan Museum in Toronto, Canada, has been established and developed by the Aga Khan Trust for Culture (AKTC), which is an agency of the Aga Khan Development Network (AKDN). Through permanent and temporary exhibitions, educational activities and performing arts, the Museum’s mission is to spark wonder, curiosity, and understanding of Muslim cultures and their connection with other cultures through the arts. Designed by architect Fumihiko Maki, the Museum shares a 6.8-hectare site with Toronto’s Ismaili Centre, which was designed by architect Charles Correa. The surrounding landscaped park was designed by landscape architect Vladimir Djurovic.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421929514/en/

Contacts

FOR PRESS INQUIRIES, PLEASE CONTACT:

Eric Tang
Front Street Partners
eric.tang@frontstreetpartners.ca
416.822.0541

Kelly Frances
Director, Marketing and Communications
Aga Khan Museum
press@agakhanmuseum.org
416.858.8735

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Frasca Pilatus PC-12 PRO Flight Training Device Receives FOCA Qualification21.4.2026 17:05:00 EEST | Press release

Frasca International, Inc., a FlightSafety International company and global leader in flight simulation, today announced that its Pilatus PC-12 PRO Flight Simulation Training Device (FSTD) received Level 2 Flight Training Device (FTD2) and Flight and Navigation Procedures Trainer (FNPT II) qualification from Switzerland’s Federal Office of Civil Aviation (FOCA). Frasca is the first to develop a PC-12 PRO training device. The device equipped with Garmin’s G3000 PRIME Avionics suite is installed at Pilatus Aircraft Ltd headquarters in Stans, Switzerland, where it will support training for the next generation of PC-12 pilots. The qualification enables pilots to complete a wide range of instruments, procedural and advanced systems training in a highly immersive environment that mirrors the capabilities of the aircraft. “The PC-12 PRO leads the way with advanced features, and we’re proud to produce a state-of-the-art simulator that allows pilots to seamlessly transition from the FTD to the

Frasca Pilatus PC-12 PRO Flight Training Device Receives FOCA Qualification21.4.2026 17:05:00 EEST | Press release

Frasca International, Inc., a FlightSafety International company and global leader in flight simulation, today announced that its Pilatus PC-12 PRO Flight Simulation Training Device (FSTD) received Level 2 Flight Training Device (FTD2) and Flight and Navigation Procedures Trainer (FNPT II) qualification from Switzerland’s Federal Office of Civil Aviation (FOCA). Frasca is the first to develop a PC-12 PRO training device. The device equipped with Garmin’s G3000 PRIME Avionics suite is installed at Pilatus Aircraft Ltd headquarters in Stans, Switzerland, where it will support training for the next generation of PC-12 pilots. The qualification enables pilots to complete a wide range of instruments, procedural and advanced systems training in a highly immersive environment that mirrors the capabilities of the aircraft. “The PC-12 PRO leads the way with advanced features, and we’re proud to produce a state-of-the-art simulator that allows pilots to seamlessly transition from the FTD to the

Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting21.4.2026 17:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured as an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago. “The positive Phase 3 frontMIND results for tafasitamab in patients with newly diagnosed diffuse large B-cell lymphoma highlight Incyte’s continued focus on advancing novel differentiated approaches with the potential to meaningfully impact patients,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “We look forward to sharing the full data at ASCO, and to progressing our pipeline.” Presentation details: frontMIND: Phase 3 Study of tafasitamab (Tafa) Plus lenalidomide (Len) and R-CHOP for Patients (pts) with Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) (Abstract #7000. Session: Oral Abstract Session

Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting21.4.2026 17:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured as an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago. “The positive Phase 3 frontMIND results for tafasitamab in patients with newly diagnosed diffuse large B-cell lymphoma highlight Incyte’s continued focus on advancing novel differentiated approaches with the potential to meaningfully impact patients,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “We look forward to sharing the full data at ASCO, and to progressing our pipeline.” Presentation details: frontMIND: Phase 3 Study of tafasitamab (Tafa) Plus lenalidomide (Len) and R-CHOP for Patients (pts) with Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) (Abstract #7000. Session: Oral Abstract Session

Andersen Global Strengthens West Africa Platform with the Addition of Member Firm in Ghana21.4.2026 16:30:00 EEST | Press release

Andersen Global continues its expansion across Africa, with Lima Partners joining as a member firm and introducing the Andersen name in Ghana. Established in 2014 and headquartered in Accra, Andersen in Ghana is led by Managing Partner Daniel Addo Okoe. The firm provides a full range of professional services, including tax advisory, regulatory compliance, accounting and advisory, transfer pricing, payroll administration, immigration, and company secretarial services to both local and international clients operating in Ghana and the wider West African region. “Becoming a member firm of Andersen Global marks a significant milestone for our organization,” said Kwame Amporful, senior partner of Andersen in Ghana. “Our clients will benefit from enhanced cross-border capabilities while continuing to receive practical, high-quality advisory services tailored to the Ghanaian market.” “Ghana plays a vital role in facilitating cross-border trade and investment within West Africa,” added Mark L.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye